{"id":43,"date":"2021-06-13T05:27:23","date_gmt":"2021-06-13T04:27:23","guid":{"rendered":"https:\/\/plusultra-pharma.de\/?page_id=43"},"modified":"2026-01-22T13:43:49","modified_gmt":"2026-01-22T12:43:49","slug":"ueber-plusultra-pharma","status":"publish","type":"page","link":"https:\/\/plusultra-pharma.de\/en\/ueber-plusultra-pharma\/","title":{"rendered":"About Plusultra pharma"},"content":{"rendered":"

[et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ custom_margin_tablet=““ custom_margin_phone=““ custom_margin_last_edited=“on|phone“ custom_padding=“37px||25px||false|false“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row _builder_version=“4.16″ _module_preset=“default“ custom_padding=“0px|0px|0px|0px|true|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_post_title meta=“off“ featured_image=“off“ _builder_version=“4.17.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ background_image=“https:\/\/plusultra-pharma.de\/wp-content\/uploads\/2021\/07\/about_us.jpg“ min_height=“445px“ min_height_tablet=“625px“ min_height_phone=“615px“ min_height_last_edited=“on|phone“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row column_structure=“1_2,1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.16″ _module_preset=“default“ text_font_size=“25px“ custom_margin=“-22px||||false|false“ custom_margin_tablet=““ custom_margin_phone=“||||false|false“ custom_margin_last_edited=“on|phone“ custom_padding=“||||false|false“ animation_style=“slide“ animation_direction=“right“ animation_duration=“1750ms“ module_alignment_tablet=““ module_alignment_phone=““ module_alignment_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

As a research and development-based pharmaceutical company, we develop pharmaceuticals for unmet needs, such as orphan drugs. Before delivering new products, we always consider the needs of our customers.<\/p>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.16″ _module_preset=“default“ da_disable_devices=“off|off|off“ global_colors_info=“{}“ da_is_popup=“off“ da_exit_intent=“off“ da_has_close=“on“ da_alt_close=“off“ da_dark_close=“off“ da_not_modal=“on“ da_is_singular=“off“ da_with_loader=“off“ da_has_shadow=“on“][et_pb_row _builder_version=“4.16″ _module_preset=“default“ background_color=“rgba(218,237,247,0.77)“ custom_margin=“-175px||||false|false“ custom_padding=“|29px||29px|false|true“ border_radii=“on|14px|14px|14px|14px“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“][et_pb_tabs module_id=“tabs“ _builder_version=“4.17.4″ _module_preset=“default“ body_line_height_tablet=““ body_line_height_phone=“1.4em“ body_line_height_last_edited=“on|phone“ global_colors_info=“{}“][et_pb_tab title=“Philosophy“ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n

Corporate Mission<\/h2>\n

Contribute to Society by Providing Critical but Neglected Pharmaceuticals and Medical Devices<\/span><\/p>\n

Management Policies<\/h2>\n

General<\/strong><\/p>\n

    \n
  1. Give priority to legal and ethical compliance in the course of business \u2013\u00a0never prioritize loyalty to company over moral.<\/li>\n
  2. Share our Mission, Policies and Code of Conduct among all stakeholders\u00a0(employees, shareholders, officers).<\/li>\n
  3. Pursue evolution of the company, yet becoming larger is not our main goal.<\/li>\n
  4. Comply with regulations and ethical codes.<\/li>\n
  5. Ensure transparency and disclosure.<\/li>\n
  6. Launch business overseas.<\/li>\n<\/ol>\n

    Personnel<\/strong><\/p>\n

      \n
    1. Value employees and families, and respect self-development.<\/li>\n
    2. Employ the principle of \u201cselect few\u201d*, and create an environment where\u00a0they can enjoy working.
      *Select few = experienced experts passionately devoted to working, irrespective of gender, age, nationality, religion or preference.<\/li>\n
    3. Value suggestions and opinions from employees.<\/li>\n<\/ol>\n

      \u00a0Products<\/strong><\/p>\n

        \n
      1. Pursue high-quality products and data.<\/li>\n
      2. Ensure post-marketing safety.<\/li>\n
      3. Search for product seeds externally.<\/li>\n<\/ol>\n

        \u00a0Capital<\/strong><\/p>\n

          \n
        1. Profits are a result of and means of achieving the Mission.<\/li>\n
        2. Focus on higher return on sales\/profits per employee.<\/li>\n
        3. Keep in mind the disadvantages of failure \u2013 not the assumption of success \u2013\u00a0when making investment decisions.<\/li>\n
        4. Profits are distributed to shareholders (dividends*), employees**, and to internal\u00a0reserves.
          *Dividends: 1\/3 of profits after tax
          **employees: up to dividends<\/li>\n
        5. Invest asset only with a principal guarantee.<\/li>\n<\/ol>\n

          Direction<\/h2>\n
          \n

          Putting ourselves in the position of people who look forward to our research progress as a research and development-based pharmaceutical company, develop pharmaceuticals for unmet needs, such as orphan drugs (for rare diseases), off-label drugs, and drugs for intractable diseases, and facilitate quick delivery of these drugs to patients and physicians in need.<\/p>\n

           <\/p>\n<\/div>\n

          Code of Conduct<\/h2>\n

          Principle<\/strong><\/p>\n

          When in doubt, the patient benefit takes priority.<\/p>\n

          \u00a0Our Challenges<\/strong><\/p>\n

            \n
          1. YMWS: \u201cY<\/strong>atte M<\/strong>inakucha W<\/strong>akaranai, shikashi S<\/strong>ongiri wo tamerauna\u201d
            = You never know how it will turn out unless you try, but do not hesitate to cut losses<\/li>\n
          2. ZY: \u201cZ<\/strong>enrei ga nainara Y<\/strong>attemiru\u201d = Even if there is no precedent, be the first to try it<\/li>\n<\/ol>\n

            Speed<\/strong><\/p>\n

              \n
            1. Never forget patients are waiting.<\/li>\n
            2. Be unafraid to buy time.<\/li>\n
            3. Set a specific deadline date* at the beginning to pursue the goal without worrying\u00a0about possible delays.
              *Stay away from \u201capproximately\/around\u201d and \u201cearly\/late\u201d, etc.<\/li>\n
            4. If problems or mistakes occur, prevent their expansion first before preventing\u00a0reoccurrence.<\/li>\n
            5. Speedy decisions by managers who have authority of million(s) yen projects*.
              *3 million for Division Manager; 1 million for Department\/Branch Manager\/PM\/PL<\/li>\n<\/ol>\n

              Cost\/Efficiency<\/strong><\/p>\n

                \n
              1. Never take or lead to wasteful actions.<\/li>\n
              2. No overtime work is considered optimal.<\/li>\n
              3. Consider patient needs, scientific rationality and laws\/regulations when pursuing\u00a0higher quality in products\/data.<\/li>\n
              4. Pursue cost reduction with the principle of multiple sources, while regarding\u00a0providers as partners.<\/li>\n<\/ol>\n

                \u00a0Communications\/Relationship<\/strong><\/p>\n

                  \n
                1. Embrace inter-departmental advice and cooperation \u2013 hiding in silos is a symptom\u00a0of \u201cBig Company\u201d Disease.<\/li>\n
                2. Superiors to confidently entrust tasks to subordinates, but never leave unmanaged.<\/li>\n
                3. Hear anyone out \u2013 never interrupt in the middle.<\/li>\n
                4. Start with conclusion\/result when explaining\/responding.<\/li>\n
                5. Greetings may seem small, but they are important.<\/li>\n<\/ol>\n

                  [\/et_pb_tab][et_pb_tab title=“Geschichte“ content_tablet=““ content_phone=“<\/p>\n

                  \n

                  \u201cNobel\u201d of our company name comes from the famous Alfred Nobel,
                  the founder of the Nobel Prize.<\/em><\/span><\/p>\n

                  <\/em><\/span><\/p>\n

                  <\/em><\/span><\/p>\n<\/blockquote>\n

                  Family Line of Nobel<\/h3>\n

                  Nobel, known for his invention of dynamite, established Nobel Industries Limited in 1870. Through the diversification by mergers, it eventually evolved into the world\u2019s leading chemical company, ICI (Imperial Chemical Industries); the business unit of which called ICI Nobel then became the current Nobel Enterprises Industries Inc. in 2002 when acquired by Inabata & Co., Ltd., and there inaugurated as its group business is our company, Nobelpharma Co., Ltd.<\/p>\n

                  Taking pride to inherit such a venerable name of Nobel, we are determined to contribute to society by providing pharmaceuticals and medical devices that only we can provide.<\/p>\n

                  In 2019, our first overseas subsidiary, Nobelpharma America, LLC was established in Bethesda, Maryland US.<\/p>\n

                  Add about Pusultra pharma<\/span><\/p>\n

                  Timeline image post here<\/span><\/p>\n

                  “ content_last_edited=“on|phone“ _builder_version=“4.16″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n

                  Die Familienline der Nobelsl<\/h2>\n

                  Nobel, der f\u00fcr die Erfindung des Dynamits bekannt ist, hat im Jahre 1870 die Firma Nobel Industries Limited gergr\u00fcndet. Durch von Zuk\u00e4ufen begr\u00fcndete Diversifikation ist daraus das weltweit f\u00fchrende Unternehmen ICI (Imperial Chemical Industries) entstanden \u2013 deren Gesch\u00e4ftsbereich, die ICI Nobel dann im Jahre 2002 zur heutigen current Nobel Enterprises Industries Inc. wurde, als sie von Inabata & Co., Ltd. aufgekauft wurde. In dieses Unternehmen wurde, als Teil der Unternehmensgruppe, unsere Firma Nobelpharma Co., Ltd. eingegliedert. \u00a0<\/p>\n

                  Stolz darauf, den ehrw\u00fcrdigen Namen Nobel zu \u00fcbernehmen, f\u00fchlen wir uns verpflichtet der Gesellschaft etwas beizusteuern, indem wir Pharmazeutika und medizinische Ger\u00e4te anbieten, welche nur wir zur Verf\u00fcgung stellen k\u00f6nnen.<\/p>\n

                  In 2020 wurden \u00dcbersee auf dem europ\u00e4ischen Kontinent unsere Tochtergesellschaften Plusultra pharma GmbH und Plusultra pharma UK Ltd. in D\u00fcsseldorf, Deutschland, und Oxford, Vereinigtes K\u00f6nigreich, gegr\u00fcndet, welche unser Andenken an die Familie Nobel weiterf\u00fchren.\u00a0\u00a0<\/p>\n

                   <\/p>\n

                   <\/p>\n

                  \"Plusultra<\/p>\n

                  [\/et_pb_tab][et_pb_tab title=“Nachrichtenarchiv“ _builder_version=“4.17.4″ _module_preset=“default“ custom_padding=“||300px||false|false“ global_colors_info=“{}“]<\/p>\n